Generate a tailored SOP for Dr. Christopher Gomez. Improve your application with a focused, well-structured draft.
Dr. Christopher M. Gomez has over 25 years of experience in the field of genetic disorders affecting the neuromuscular junction, particularly congenital myasthenic syndromes, and the cerebellum. His long-term goal is to characterize the pathogenic mechanisms that cause ataxia and to develop treatments that include identifying disease stage-specific biomarkers for ataxia. Dr. Gomez is an expert in neurogenetic disorders, gait, and balance disorders, and the diagnosis and treatment of patients with ataxias, which includes rare neurodegenerative diseases. In 2006, he established the University of Chicago Ataxia Center, a specialty clinic and research center dedicated to the diagnosis, treatment, and management of ataxias, focusing on translational clinical research. He has served on the medical research advisory board of the National Ataxia Foundation and was a past chair of the Neurogenetics Section of the American Academy of Neurology. With more than 50 peer-reviewed publications, Dr. Gomez's laboratory focuses on the molecular and cellular mechanisms of neurodegenerative diseases, particularly examining genetic mutations in ion channels that lead to dominantly inherited neurodegenerative diseases.
Department of Philosophy